ACADIA HEALTHCARE CO INC (ACHC) Stock Fundamental Analysis
NASDAQ:ACHC - US00404A1097 - Common Stock
23.45 USD
+0.49 (+2.13%)
23.45 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to ACHC. ACHC was compared to 102 industry peers in the Health Care Providers & Services industry. While ACHC is still in line with the averages on profitability rating, there are concerns on its financial health. ACHC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ACHC had positive earnings in the past year.
In the past year ACHC had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
Each year in the past 5 years ACHC had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 2.21%, ACHC perfoms like the industry average, outperforming 59.80% of the companies in the same industry.
ACHC has a Return On Equity of 4.52%. This is in the better half of the industry: ACHC outperforms 60.78% of its industry peers.
ACHC has a Return On Invested Capital of 6.31%. This is in the better half of the industry: ACHC outperforms 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACHC is in line with the industry average of 9.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 4.52% | ||
| ROIC | 6.31% |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
1.3 Margins
ACHC has a better Profit Margin (4.31%) than 75.49% of its industry peers.
In the last couple of years the Profit Margin of ACHC has grown nicely.
ACHC has a Operating Margin of 14.60%. This is amongst the best in the industry. ACHC outperforms 86.27% of its industry peers.
ACHC's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.6% | ||
| PM (TTM) | 4.31% | ||
| GM | N/A |
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ACHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ACHC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ACHC has been increased compared to 5 years ago.
ACHC has a worse debt/assets ratio than last year.
2.2 Solvency
ACHC has an Altman-Z score of 1.28. This is a bad value and indicates that ACHC is not financially healthy and even has some risk of bankruptcy.
ACHC has a Altman-Z score of 1.28. This is in the lower half of the industry: ACHC underperforms 65.69% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that ACHC is somewhat dependend on debt financing.
ACHC has a Debt to Equity ratio (0.73) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.28 |
ROIC/WACC0.72
WACC8.75%
2.3 Liquidity
A Current Ratio of 1.32 indicates that ACHC should not have too much problems paying its short term obligations.
With a Current ratio value of 1.32, ACHC perfoms like the industry average, outperforming 42.16% of the companies in the same industry.
ACHC has a Quick Ratio of 1.31. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.31, ACHC perfoms like the industry average, outperforming 46.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.80%.
Measured over the past years, ACHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.21% on average per year.
ACHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.64%.
ACHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.45% yearly.
EPS 1Y (TTM)-20.8%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-8.79%
Revenue 1Y (TTM)5.64%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%9.19%
3.2 Future
Based on estimates for the next years, ACHC will show a small growth in Earnings Per Share. The EPS will grow by 5.66% on average per year.
Based on estimates for the next years, ACHC will show a quite strong growth in Revenue. The Revenue will grow by 8.46% on average per year.
EPS Next Y-21.25%
EPS Next 2Y-7.24%
EPS Next 3Y-3.42%
EPS Next 5Y5.66%
Revenue Next Year5.21%
Revenue Next 2Y6.3%
Revenue Next 3Y6.71%
Revenue Next 5Y8.46%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ACHC is valuated reasonably with a Price/Earnings ratio of 8.44.
Compared to the rest of the industry, the Price/Earnings ratio of ACHC indicates a rather cheap valuation: ACHC is cheaper than 95.10% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.90, ACHC is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.26, the valuation of ACHC can be described as very reasonable.
Based on the Price/Forward Earnings ratio, ACHC is valued cheaper than 92.16% of the companies in the same industry.
ACHC is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.44 | ||
| Fwd PE | 8.26 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACHC is valued cheaper than 87.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.67 |
4.3 Compensation for Growth
A cheap valuation may be justified as ACHC's earnings are expected to decrease with -3.42% in the coming years.
PEG (NY)N/A
PEG (5Y)0.83
EPS Next 2Y-7.24%
EPS Next 3Y-3.42%
5. Dividend
5.1 Amount
No dividends for ACHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.45
+0.49 (+2.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.82%
Inst Owner Change4.14%
Ins Owners1.38%
Ins Owner Change7.75%
Market Cap2.17B
Analysts82
Price Target32.13 (37.01%)
Short Float %11.89%
Short Ratio4.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.54%
Min EPS beat(2)9.95%
Max EPS beat(2)17.12%
EPS beat(4)2
Avg EPS beat(4)3.4%
Min EPS beat(4)-12.21%
Max EPS beat(4)17.12%
EPS beat(8)6
Avg EPS beat(8)2.94%
EPS beat(12)9
Avg EPS beat(12)10.71%
EPS beat(16)11
Avg EPS beat(16)8.23%
Revenue beat(2)1
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-1.88%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)1.45%
Revenue beat(8)3
Avg Revenue beat(8)-0.97%
Revenue beat(12)5
Avg Revenue beat(12)-0.63%
Revenue beat(16)5
Avg Revenue beat(16)-0.82%
PT rev (1m)-24.74%
PT rev (3m)-32.09%
EPS NQ rev (1m)-19.04%
EPS NQ rev (3m)-27.03%
EPS NY rev (1m)-3.63%
EPS NY rev (3m)-4.11%
Revenue NQ rev (1m)-3.25%
Revenue NQ rev (3m)-4.31%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.44 | ||
| Fwd PE | 8.26 | ||
| P/S | 0.67 | ||
| P/FCF | N/A | ||
| P/OCF | 5.1 | ||
| P/B | 0.7 | ||
| P/tB | 3 | ||
| EV/EBITDA | 6.67 |
EPS(TTM)2.78
EY11.86%
EPS(NY)2.84
Fwd EY12.11%
FCF(TTM)-3.37
FCFYN/A
OCF(TTM)4.6
OCFY19.62%
SpS34.97
BVpS33.33
TBVpS7.82
PEG (NY)N/A
PEG (5Y)0.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 4.52% | ||
| ROCE | 8.15% | ||
| ROIC | 6.31% | ||
| ROICexc | 6.45% | ||
| ROICexgc | 11.06% | ||
| OM | 14.6% | ||
| PM (TTM) | 4.31% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ROICexc(3y)8.08%
ROICexc(5y)7.37%
ROICexgc(3y)16.06%
ROICexgc(5y)14.72%
ROCE(3y)10.25%
ROCE(5y)9.25%
ROICexcg growth 3Y-4.56%
ROICexcg growth 5Y16.02%
ROICexc growth 3Y1.65%
ROICexc growth 5Y14.56%
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.49 | ||
| Cap/Depr | 424.98% | ||
| Cap/Sales | 22.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 65.9% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 1.28 |
F-Score6
WACC8.75%
ROIC/WACC0.72
Cap/Depr(3y)344.44%
Cap/Depr(5y)299.77%
Cap/Sales(3y)15.9%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.8%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-8.79%
EPS Next Y-21.25%
EPS Next 2Y-7.24%
EPS Next 3Y-3.42%
EPS Next 5Y5.66%
Revenue 1Y (TTM)5.64%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%9.19%
Revenue Next Year5.21%
Revenue Next 2Y6.3%
Revenue Next 3Y6.71%
Revenue Next 5Y8.46%
EBIT growth 1Y-11.21%
EBIT growth 3Y9.61%
EBIT growth 5Y10.7%
EBIT Next Year23.12%
EBIT Next 3Y13.7%
EBIT Next 5Y11.46%
FCF growth 1Y-846.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.09%
OCF growth 3Y-29.78%
OCF growth 5Y-15.9%